Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo-Reference-Cited by-同舟云学术

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

Published:2007-09 Issue:3 Volume:30 Page:229-235
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Seifert Karin,Pérez-Victoria F. Javier,Stettler Marianne,Sánchez-Cañete María P.,Castanys Santiago,Gamarro Francisco,Croft Simon L.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda;Guerin;Lancet Infect Dis,2002

2. Chemotherapy of trypanosomiases and leishmaniasis;Croft;Trends Parasitol,2005

3. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer;Terwogt;Br J Cancer,1999

4. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani;Croft;Biochem Pharmacol,1987

5. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice;Kuhlencord;Antimicrob Agents Chemother,1992

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene editing and scalable functional genomic screening in Leishmania species using the CRISPR/Cas9 cytosine base editor toolbox LeishBASEedit;eLife;2023-05-24

2. Miltefosine Unresponsiveness in Visceral Leishmaniasis;Challenges and Solutions Against Visceral Leishmaniasis;2023

3. Introducing the CRISPR/Cas9 cytosine base editor toolbox ‘LeishBASEedit’ – Gene editing and high-throughput screening inLeishmaniawithout requiring DNA double-strand breaks, homologous recombination or donor DNA;2022-12-08

4. Transcriptome Analysis of Intracellular Amastigotes of Clinical Leishmania infantum Lines from Therapeutic Failure Patients after Infection of Human Macrophages;Microorganisms;2022-06-27

5. Advances in Computational Techniques for Discovery and Development of Drugs Against Leishmaniasis, a Brief Review;Research Topics in Bioactivity, Environment and Energy;2022